Chemical Management Strategy for Toys
The webinar will provide participants with a better understanding of what chemical management in toys is, why companies need it, and how to begin the process of getting it.
Who Should Attend:
Open to all toy industry stakeholders, recommended for those who work on toy design, production, manufacturing, and quality.
Thursday, January 17, 2013 | 1:30 - 3:00 pm (Eastern)
As with other TIA webinars, the session will be recorded and available post-event for those who are unable to participate live.
Advance registration is available via the following links:
Topics to be covered during this session discussing Chemical Management Strategy for Toys include:
- Why companies need it
A Review of recent legislation, discussion of the trend of the role of NGO’s and retailers
- What it looks like
Including broad spectrum, a primer on risk assessment, engaging suppliers, and resources needed by companies
- How to get started in having it
First steps to take, inventorying product, understanding map supply and chain and how to prioritize
- Available solutions
Alan P. Kaufman, TIA vice president of technical affairs
Thomas G. Osimitz, Ph.D., Founder, Science Strategies, LLC, Cofounder, SciVera, LLC
Thomas Osimitz has over thirty years of experience in toxicology. He is founder and Principal of Science Strategies, LLC, a consulting firm that helps companies of all sizes to negotiate the turbulent intersection of science, policy, and product development. He is also cofounder of SciVera, LLC, a software-as-a-service company that enables rapid hazard and risk assessment of chemicals, materials, and products. Prior to founding Science Strategies in 2002, he was Vice-President for Global Safety Assessment/Regulatory Affairs and Sustainable Product Innovation for S.C. Johnson and Son.
Thomas has done extensive work in developmental neurotoxicology, endocrine toxicology, and risk assessment, experience that he brings to bear on chemical assessments and the design of chemical management strategies. He is leading ongoing research programs in endocrine disruption, the relevance of rodent carcinogens to humans, and the use of physiologically based pharmacokinetic models to examine the possible differences in the sensitivity of adults and children to neurotoxic chemicals.
Thomas has a special passion for enhancing collaboration and productivity between chemists and toxicologists with the goal of designing safer chemicals (a key part of alternative assessments) and has forged several such interactions.
He has a B.S. in Biology from The University of Minnesota, and a Ph.D. in Toxicology from The University of Michigan. He is certified in Toxicology by the American Board of Toxicology and is certified as a European Registered Toxicologist by the International Union of Toxicology (IUTOX).
Questions from members and industry stakeholders may be submitted in advance to TIA’s Jackie Retzer; to the extent possible, answers to these questions will be folded into the presentation.